These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17671136)

  • 1. Corruption of the Fas pathway delays the pulmonary clearance of murine osteosarcoma cells, enhances their metastatic potential, and reduces the effect of aerosol gemcitabine.
    Gordon N; Koshkina NV; Jia SF; Khanna C; Mendoza A; Worth LL; Kleinerman ES
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4503-10. PubMed ID: 17671136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MSP-4, an Antimicrobial Peptide, Induces Apoptosis via Activation of Extrinsic Fas/FasL- and Intrinsic Mitochondria-Mediated Pathways in One Osteosarcoma Cell Line.
    Kuo HM; Tseng CC; Chen NF; Tai MH; Hung HC; Feng CW; Cheng SY; Huang SY; Jean YH; Wen ZH
    Mar Drugs; 2018 Jan; 16(1):. PubMed ID: 29301308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipancreatic cancer effect of DNT cells and the underlying mechanism.
    Chen J; Hu P; Wu G; Zhou H
    Pancreatology; 2019 Jan; 19(1):105-113. PubMed ID: 30579733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hybrid liposomes inhibit tumor growth and lung metastasis of murine osteosarcoma cells.
    Kitajima H; Komizu Y; Ichihara H; Goto K; Ueoka R
    Cancer Med; 2013 Jun; 2(3):267-76. PubMed ID: 23930203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fas and Fas ligand interactions suppress melanoma lung metastasis.
    Owen-Schaub LB; van Golen KL; Hill LL; Price JE
    J Exp Med; 1998 Nov; 188(9):1717-23. PubMed ID: 9802983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host-derived growth factors drive ERK phosphorylation and MCL1 expression to promote osteosarcoma cell survival during metastatic lung colonization.
    McAloney CA; Makkawi R; Budhathoki Y; Cannon MV; Franz EM; Gross AC; Cam M; Vetter TA; Duhen R; Davies AE; Roberts RD
    Cell Oncol (Dordr); 2024 Feb; 47(1):259-282. PubMed ID: 37676378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune reconstitution prevents metastatic recurrence of murine osteosarcoma.
    Merchant MS; Melchionda F; Sinha M; Khanna C; Helman L; Mackall CL
    Cancer Immunol Immunother; 2007 Jul; 56(7):1037-46. PubMed ID: 17149595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological prevention of surgery-accelerated metastasis in an animal model of osteosarcoma.
    Kallis MP; Maloney C; Blank B; Soffer SZ; Symons M; Steinberg BM
    J Transl Med; 2020 Apr; 18(1):183. PubMed ID: 32354335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled Medicines for Targeting Non-Small Cell Lung Cancer.
    Al Khatib AO; El-Tanani M; Al-Obaidi H
    Pharmaceutics; 2023 Dec; 15(12):. PubMed ID: 38140117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breaking down the tumor immune infiltration within pediatric sarcomas.
    Weil R; Loeb D
    Front Endocrinol (Lausanne); 2023; 14():1187289. PubMed ID: 37424864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteosarcoma and Metastasis.
    Sheng G; Gao Y; Yang Y; Wu H
    Front Oncol; 2021; 11():780264. PubMed ID: 34956899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospects for NK Cell Therapy of Sarcoma.
    Lachota M; Vincenti M; Winiarska M; Boye K; Zagożdżon R; Malmberg KJ
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33322371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bempegaldesleukin (BEMPEG; NKTR-214) efficacy as a single agent and in combination with checkpoint-inhibitor therapy in mouse models of osteosarcoma.
    Hennessy M; Wahba A; Felix K; Cabrera M; Segura MG; Kundra V; Ravoori MK; Stewart J; Kleinerman ES; Jensen VB; Gopalakrishnan V; Pena R; Quach P; Kim G; Kivimäe S; Madakamutil L; Overwijk WW; Zalevsky J; Gordon N
    Int J Cancer; 2021 Apr; 148(8):1928-1937. PubMed ID: 33152115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural Killer Cell Immunotherapy for Osteosarcoma.
    Tullius BP; Setty BA; Lee DA
    Adv Exp Med Biol; 2020; 1257():141-154. PubMed ID: 32483737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Histone Deacetylase Inhibitor Entinostat/Syndax 275 in Osteosarcoma.
    Kiany S; Harrison D; Gordon N
    Adv Exp Med Biol; 2020; 1257():75-83. PubMed ID: 32483732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103
    Zhou Y; Slone N; Chrisikos TT; Kyrysyuk O; Babcock RL; Medik YB; Li HS; Kleinerman ES; Watowich SS
    J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32273347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding and Modeling Metastasis Biology to Improve Therapeutic Strategies for Combating Osteosarcoma Progression.
    Fan TM; Roberts RD; Lizardo MM
    Front Oncol; 2020; 10():13. PubMed ID: 32082995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate Immune Cells: A Potential and Promising Cell Population for Treating Osteosarcoma.
    Wang Z; Wang Z; Li B; Wang S; Chen T; Ye Z
    Front Immunol; 2019; 10():1114. PubMed ID: 31156651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aerosol Gemcitabine after Amputation Inhibits Osteosarcoma Lung Metastases but Not Wound Healing.
    Kleinerman ES; Yu L; Dao J; Hayes-Jordan AA; Lindsey B; Kawedia JD; Stewart J; Gordon N
    Sarcoma; 2018; 2018():3143096. PubMed ID: 29610563
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.